Dose reduced conditioning and allogeneic stem cell transplantation in 36 patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

被引：0
|
作者：
Bornhäuser, M
Schaich, M
Schaekel, U
Mahlberg, R
Clemens, M
Ehninger, G
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [1] Dose reduced conditioning and allogeneic stem cell transplantation in 34 patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Bornhauser, M
    Kroschinsky, F
    Ulrike, S
    Markus, S
    Eberhard, S
    Ralph, N
    Thiede, C
    Ulrich, S
    Gerhard, E
    [J]. BLOOD, 2000, 96 (11) : 780A - 780A
  • [2] Prognostic factors for allogeneic stem cell transplantation (ASCT) for refractory acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS).
    Wong, R
    Shahjahan, M
    De Lima, M
    Anagnostopoulos, A
    Estey, E
    Champlin, R
    Andersson, B
    Khouri, I
    Giralt, S
    [J]. BLOOD, 2002, 100 (11) : 853A - 853A
  • [3] Trends in hospitalization outcomes of elderly patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia/myelodysplastic syndrome (AML/MDS).
    Murthy, Guru Subramanian Guru
    Mehta, Paulette
    Jethava, Yogesh
    Dhakal, Ishwori
    Makhoul, Issam
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Allogeneic haematopoietic stem cell transplantation for elderly patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): A single center analysis
    Katayama, Y.
    Iwato, K.
    Ohchi, T.
    Okatani, T.
    Imanaka, R.
    Kyo, K.
    Itagaki, M.
    Katsutani, S.
    Kyo, T.
    Asaoku, H.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S475 - S476
  • [5] Efficacy of Lenalidomide and Bortezomib for Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing after Allogeneic Stem Cell Transplantation
    Brunner, Andrew M.
    Blonquist, Traci M.
    McMasters, Malgorzata
    Hobbs, Gabriela S.
    McAfee, Steven L.
    Rosenblatt, Jacalyn
    Amrein, Philip C.
    Connolly, Christine
    Ramos, Aura Y.
    Mikami, Kaleb
    Logan, Emma
    Dey, Bimalangshu R.
    Spitzer, Thomas
    Avigan, David E.
    Chen, Yi-Bin
    Ballen, Karen K.
    El-Jawahri, Areej
    Fathi, Amir T.
    [J]. BLOOD, 2018, 132
  • [6] Mixed chimerism after allogeneic hematopoietic stem cell transplantation (HSCT) for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
    de Lima, M
    Carrasco, A
    Lee, MS
    Saliba, R
    Glassman, A
    Anagnostopoulos, A
    Couriel, D
    Caldera, H
    Andersson, BS
    El-Zimaity, M
    Giralt, S
    Champlin, R
    [J]. BLOOD, 2003, 102 (11) : 707A - 707A
  • [7] Evaluation of reduced intensity allogeneic hematopoietic stem cell transplantation (HSCT) using anti lymphocyte antibodies in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Popat, UR
    Carrum, G
    Krance, R
    Brenner, M
    Heslop, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 568S - 568S
  • [8] Dose-reduced conditioning followed by allogeneic stem cell transplantation in patients with MDS or secondary AML
    Kröger, N
    Schwerdtfeger, R
    Bornhäuser, M
    Ehninger, G
    Runde, V
    Beyer, J
    Kiehl, M
    Schetelig, J
    Siegert, W
    Schäfer-Eckert, K
    Wandt, H
    Sayer, HG
    Kröger, M
    Zabelina, T
    Zander, AR
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S57 - S57
  • [9] Acute myeloid leukemia (AML) and Myelodysplastic syndrome (MDS) associated with Monosomy 7: Management by allogeneic hematopoietic stem cell transplantation (HSCT)
    Giller, RH
    Trobaugh, AD
    Hunger, SP
    Malcolm, J
    Schissel, D
    Hild, E
    Quinones, RR
    [J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 251A - 251A
  • [10] Lack of impact of comorbidities on outcomes of allogeneic stem cell transplantation (ASCT) for refractory acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS)
    Wong, RS
    Shahjahan, M
    Alamo, J
    de Lima, M
    Khouri, I
    Gajewski, J
    Andersson, B
    Champlin, R
    Giralt, S
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 31 - 31
12345